Genuv Inc.
PrivateLast Round
Grant
Feb 1, 2024
Total Funding Raised
$24.41M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Genuv Inc. operates in Healthcare & Life Sciences and is based in Seoul. Its latest recorded funding round was a Grant round in February 2024.
Genuv Inc. is a biotechnology company that develops treatments for neurodegenerative diseases and immuno-oncology therapeutics using proprietary drug discovery platforms.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genuv Inc. Comparables
Compare Genuv Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Harbour BioMed | 75% | |
| Alloy Therapeutics | 74% | |
| Biocytogen | 70% |
For institutional investors. Book with your work email.
Genuv Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 1, 2024 | ||||
| Accelerator | Dec 12, 2022 | ||||
| Grant | Dec 10, 2021 | ||||
| Early Funding | Dec 1, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Genuv Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kite Entrepreneurship Foundation | Accelerator |
| Korea Drug Development Fund | Grant |
| Alzheimer's Drug Discovery Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 118% MoM, reaching 5.4K.
- May 19, 2026
Monthly visitors increased 58% MoM.
For institutional investors. Book with your work email.
Genuv Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Genuv Inc.'s valuation, stock price, and market status.
Is Genuv Inc. a public or private company?
Genuv Inc. is a private company.
What is the current stock price of Genuv Inc.?
Genuv Inc. is a private company, so its shares have no public market price. Caplight tracks Genuv Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Genuv Inc. worth (valuation)?
Valuation information for Genuv Inc. is not publicly available.
Can I buy Genuv Inc. stock?
Genuv Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Genuv Inc.'s last funding round?
Genuv Inc.'s most recent funding round was Grant on February 1, 2024.
Who are the main investors in Genuv Inc.?
Key investors in Genuv Inc. include Kite Entrepreneurship Foundation, Korea Drug Development Fund, Alzheimer's Drug Discovery Foundation.
Will Genuv Inc. IPO soon?
No public IPO plans have been announced for Genuv Inc..
How can I track Genuv Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Genuv Inc.'s shares on secondary markets.